Indoco gets EIR from US FDA for its solid dosages facility (Plant I) in Verna, Goa
Indoco Remedies Ltd, a fully integrated, research-oriented pharma company, announced the receipt of an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (FDA) for their facility for solid dosages (Plant I) located in Verna, Goa.
The recent inspection held from January 16, 2023, to January 20, 2023, was a surveillance inspection.
The receipt of the EIR with VAI status also signifies the imminent closeout of the Warning Letter issued by the US FDA in July 2019 for the manufacturing site, situated at L-14, Verna Industrial Road, Goa (Plant I).
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Commenting on this positive development, Aditi Kare Panandikar, managing director
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!